Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,040 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Analgesic Efficacy and Safety of Low-Dose Transdermal Fentanyl and Oral Oxycodone in Opioid-Naïve Patients with Cancer Pain.
Kawana M, Miyasato A, Funato M, Nagatani K, Suzuki N, Onoda C, Fujimoto H, Ohno R, Kusakabe A, Kiribayashi M, Nakamura K, Kondo M, Ozeki A, Okamoto K, Kokubun H. Kawana M, et al. Among authors: suzuki n. Biol Pharm Bull. 2023;46(10):1444-1450. doi: 10.1248/bpb.b23-00331. Biol Pharm Bull. 2023. PMID: 37779046 Free article.
Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD.
Imai J, Takashimizu S, Suzuki N, Ohshinden K, Sawamoto K, Mishima Y, Tsuruya K, Arase Y, Yamano M, Kishimoto N, Yamada C, Inoue N, Moriyama K, Baba A, Suzuki H, Kagawa T, Nishizaki Y. Imai J, et al. Among authors: suzuki n. Sci Rep. 2024 Jun 11;14(1):13411. doi: 10.1038/s41598-024-64301-3. Sci Rep. 2024. PMID: 38862756 Free PMC article.
Sustained Clinical Complete Response after Discontinuation of Trastuzumab-deruxetecan Due to Interstitial Pneumonia for HER2-positive Gastric adenocarcinoma with Enteroblastic Differentiation (GAED): A Case Report.
Suzuki N, Odawara N, Fujisawa G, Ishibashi R, Hata M, Oya Y, Tamada K, Hayashi T, Abe S, Miyakawa Y, Hayakawa Y, Shinozaki-Ushiku A, Ushiku T, Boku N, Fujishiro M. Suzuki N, et al. Intern Med. 2024 Jun 6. doi: 10.2169/internalmedicine.3155-23. Online ahead of print. Intern Med. 2024. PMID: 38839335 Free article.
Safety and efficacy of aceneuramic acid in GNE myopathy: open-label extension study.
Suzuki N, Mori-Yoshimura M, Katsuno M, Takahashi MP, Yamashita S, Oya Y, Hashizume A, Yamada S, Nakamori M, Izumi R, Kato M, Warita H, Tateyama M, Kuroda H, Asada R, Yamaguchi T, Nishino I, Aoki M. Suzuki N, et al. J Neurol Neurosurg Psychiatry. 2024 Jun 5:jnnp-2024-333853. doi: 10.1136/jnnp-2024-333853. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38839274 Free article. No abstract available.
A phase 1/1b, open-label, dose-escalation study of PD-1 inhibitor, cetrelimab alone and in combination with FGFR inhibitor, erdafitinib in Japanese patients with advanced solid tumors.
Yamamoto N, Kuboki Y, Harano K, Koyama T, Kondo S, Hagiwara A, Suzuki N, Fujikawa E, Toyoizumi K, Mukai M, Doi T. Yamamoto N, et al. Among authors: suzuki n. Invest New Drugs. 2024 Jun 4. doi: 10.1007/s10637-024-01433-3. Online ahead of print. Invest New Drugs. 2024. PMID: 38833067
6,040 results